Loading Events

« All Events

  • This event has passed.

Global Regulatory Pathway Strategy: Navigating Health Technology Product Launches for Success

February 27 @ 3:00 pm - 4:30 pm


Life Sciences Nova Scotia in partnership with RQMIS Inc is pleased to invite you to join us for LSNS Educates.

Taking a medical device, novel therapeutic, diagnostic tool or digital health technology to global markets is complex. It requires a coordinated effort across several principle areas including regulatory strategy and compliance, clinical study design and management, quality systems design and risk management. RQMIS Inc. with locations in Boston Massacheusettes, London UK and Barcelona Spain has been a global provider of choice for development of regulatory and insurance strategy implementation globally for over 14 years.

Join us Tue Feb 27th where Barry Sands, President and Founder of RQMIS Inc. will share an overview and glean insights into the regulatory hurdles and strategies that must be considered for the success of healthcare commercialization in the US, UK, EU and Canadian markets.

Event Details
When: Tuesday Feb 27th
Time: 3:00pm – 4:30pm
Where: Life Sciences Research Institute – Executive Boardroom
Space is limited – Reserve (BELOW) your spot by Mon Feb 26th

Our Presenter 

Barry Sands is a biomedical engineer with a chemical engineering concentration. Barry holds an MBA and 24 years of experience in regulatory, clinical, and quality affairs for medical device and biotech companies and along with seven years of experience as a Biomedical Engineer and Sr. Scientific Reviewer at FDA/CDRH/ODE and FDA’s Boston District. Barry has provided companies with regulatory and clinical strategic advice on bringing novel technologies to the United States and EU markets in the clinical fields of orthopaedics/neurosurgery/diabetic care (spine, restorative/reconstructive, sports medicine and wound healing), gastroenterology, urology, gynecology, pulmonology, cardiology, plastic surgery (endoscopy, laparoscopy, minimally invasive, biliary stents). The devices involved have included active implantables, long term implants, electromechanical, ultrasonic imaging and PACS products.
(35) Barry Sands | LinkedIn


Our Partners

Medical Device Regulatory Consulting – RQMIS



February 27
3:00 pm - 4:30 pm


Life Sciences Research Institute – 1344 Summer St.
1344 Summer Street
Halifax, Nova Scotia B3H0A8 Canada
+ Google Map
View Venue Website